Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Defining the surgical management of suspected early-stage ovarian cancer by estimating patient numbers through alternative management strategies.

Warwick J, Vardaki E, Fattizzi N, McNeish I, Jeyarajah A, Oram D, Hassan L, Covens A, Duffy S, Reynolds K.

BJOG. 2009 Aug;116(9):1225-41. doi: 10.1111/j.1471-0528.2009.02213.x. Epub 2009 May 28.

PMID:
19485991
[PubMed - indexed for MEDLINE]
2.

The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy.

Signorelli M, Fruscio R, Ceppi L, Dell'anna T, Vitobello D, Chiappa V, Siesto G, Milani R, Landoni F, Mangioni C.

Gynecol Oncol. 2014 Feb;132(2):312-5. doi: 10.1016/j.ygyno.2014.01.001. Epub 2014 Jan 11.

PMID:
24423881
[PubMed - indexed for MEDLINE]
3.

Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.

Powless CA, Aletti GD, Bakkum-Gamez JN, Cliby WA.

Gynecol Oncol. 2011 Sep;122(3):536-40. doi: 10.1016/j.ygyno.2011.05.001. Epub 2011 Jun 1.

PMID:
21636114
[PubMed - indexed for MEDLINE]
4.

Lymph node metastasis in stage I epithelial ovarian cancer.

Suzuki M, Ohwada M, Yamada T, Kohno T, Sekiguchi I, Sato I.

Gynecol Oncol. 2000 Nov;79(2):305-8.

PMID:
11063662
[PubMed - indexed for MEDLINE]
5.

Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.

Aletti GD, Dowdy S, Podratz KC, Cliby WA.

Am J Obstet Gynecol. 2006 Dec;195(6):1862-8.

PMID:
17132488
[PubMed - indexed for MEDLINE]
6.

Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.

Ditto A, Martinelli F, Reato C, Kusamura S, Solima E, Fontanelli R, Haeusler E, Raspagliesi F.

Ann Surg Oncol. 2012 Nov;19(12):3849-55. doi: 10.1245/s10434-012-2439-7. Epub 2012 Jun 16.

PMID:
22707110
[PubMed - indexed for MEDLINE]
7.

Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.

Brockbank E, Kokka F, Bryant A, Pomel C, Reynolds K.

Cochrane Database Syst Rev. 2013 Mar 28;3:CD008217. doi: 10.1002/14651858.CD008217.pub3. Review.

PMID:
23543561
[PubMed - indexed for MEDLINE]
8.

[The surgical treatment of ovarian cancer].

Burghardt E, Lahousen M, Stettner H.

Geburtshilfe Frauenheilkd. 1990 Sep;50(9):670-7. German.

PMID:
2272432
[PubMed - indexed for MEDLINE]
9.

Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.

Brockbank E, Kokka F, Bryant A, Pomel C, Reynolds K.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD008217. doi: 10.1002/14651858.CD008217.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD008217.

PMID:
21491407
[PubMed - indexed for MEDLINE]
10.

Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study.

Saygili U, Guclu S, Uslu T, Erten O, Ture S, Demir N.

J Surg Oncol. 2002 Nov;81(3):132-7.

PMID:
12407725
[PubMed - indexed for MEDLINE]
11.

Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.

Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J.

Int J Gynecol Cancer. 2010 Aug;20(6):1000-5. doi: 10.1111/IGC.0b013e3181d80aff.

PMID:
20683408
[PubMed - indexed for MEDLINE]
12.

Update on lymphadenectomy in early and advanced ovarian cancer.

Angioli R, Plotti F, Palaia I, Calcagno M, Montera R, Cafà EV, Sereni MI, Panici PB.

Curr Opin Obstet Gynecol. 2008 Feb;20(1):34-9. doi: 10.1097/GCO.0b013e3282f2fd68. Review.

PMID:
18197003
[PubMed - indexed for MEDLINE]
13.

[Therapeutic and prognostic value of lymphadenectomy in gynecological oncology].

Perzyło K, Miotła P, Lis E, Rechberger T.

Ginekol Pol. 2013 Jul;84(7):630-6. Review. Polish.

PMID:
24032276
[PubMed - indexed for MEDLINE]
14.

Lymph node-positive stage IIIC ovarian cancer: a separate entity?

Berek JS.

Int J Gynecol Cancer. 2009 Dec;19 Suppl 2:S18-20. doi: 10.1111/IGC.0b013e3181bf8111. Review.

PMID:
19955908
[PubMed - indexed for MEDLINE]
15.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
[PubMed - indexed for MEDLINE]
16.
17.

[Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].

Tu H, Huang H, Huang QD, Li Z, Feng YL, Liu JH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Dec;47(12):928-33. Chinese.

PMID:
23324194
[PubMed - indexed for MEDLINE]
18.

The effect of chemotherapy on lymph node metastases in ovarian cancer.

Burghardt E, Winter R.

Baillieres Clin Obstet Gynaecol. 1989 Mar;3(1):167-71. Review.

PMID:
2661090
[PubMed - indexed for MEDLINE]
19.

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Winter-Roach BA, Kitchener HC, Dickinson HO.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004706. doi: 10.1002/14651858.CD004706.pub2. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD004706.

PMID:
19160239
[PubMed - indexed for MEDLINE]
20.

Controversies in the management of ovarian cancer--pros and cons for lymph node dissection in ovarian cancer.

Camara O, Sehouli J.

Anticancer Res. 2009 Jul;29(7):2837-43.

PMID:
19596971
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk